GB Sciences, Inc. (GBLX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
+0.0001 (100.00%)
At close: Nov 9, 2026
GB Sciences Market Cap
GB Sciences has a market cap or net worth of $105.88 thousand as of November 9, 2026. It is the 51,209th most valuable company in the world and the 7,241st biggest in the United States. Its market cap has decreased by 31.12% in one year.
Market Cap
105.88K
Enterprise Value
2.10M
Revenue
97.24K
Global Rank
Country Rank
#7,241 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since March 19, 2014, GB Sciences's market cap has decreased from 2.53M to 105.88K, a decrease of -95.82%. That is a compound annual growth rate of -22.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 105.88K | -58.67% |
| Dec 31, 2025 | 256.20K | -84.27% |
| Dec 31, 2024 | 1.63M | -36.83% |
| Dec 29, 2023 | 2.58M | -61.28% |
| Dec 30, 2022 | 6.66M | 2.29% |
| Dec 31, 2021 | 6.51M | -44.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PaxMedica | 88.39K |
| ProtoKinetix | 82.33K |
| Vincerx Pharma | 78.51K |
| U.S. Stem Cell | 66.15K |
| Affymax | 59.59K |
| Panbela Therapeutics | 53.89K |
| Itoco | 42.82K |
| Nascent Biotech | 34.57K |